Mercaptopurine description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Mercaptopurine

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING

CAUTION
Mercaptopurine is a potent drug. It should not be used unless a diagnosis of acute lymphatic leukemia has been adequately established and the responsible physician is experienced with the risks of mercaptopurine and knowledgeable in assessing response to chemotherapy.


MERCAPTOPURINE DESCRIPTION



Mercaptopurine




CLINICAL PHARMACOLOGY

Mechanism of action




PHARMACOKINETICS




PRECAUTIONSDOSAGE AND ADMINISTRATION

Metabolism and Genetic Polymorphism
WARNINGSPRECAUTIONSWARNINGSPRECAUTIONSWARNINGSPRECAUTIONSLaboratory TestsDOSAGE AND ADMINISTRATION
PRECAUTIONSDOSAGE AND ADMINISTRATION


INDICATIONS & USAGE





MERCAPTOPURINE CONTRAINDICATIONS




WARNINGS



Bone Marrow Toxicity

DOSAGE AND ADMINISTRATION
PRECAUTIONSDrug InteractionsDOSAGE AND ADMINISTRATION

Hepatotoxicity





Immunosuppression


Pregnancy

Pregnancy Category D



PRECAUTIONS

General


INFORMATION FOR PATIENTS



LABORATORY TESTS

WARNINGSBone Marrow Toxicity

TPMT Testing


DRUG INTERACTIONS





WARNINGS

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY




PREGNANCY

Teratogenic Effects

Pregnancy Category D
WARNINGS

NURSING MOTHERS



PEDIATRIC USE

DOSAGE AND ADMINISTRATION

GERIATRIC USE



MERCAPTOPURINE ADVERSE REACTIONS

WARNINGSPRECAUTIONS

Hematologic
WARNINGSBone Marrow Toxicity

Renal


Gastrointestinal


Miscellaneous




OVERDOSAGE




DOSAGE & ADMINISTRATION

Maintenance Therapy



Dosage with concomitant Allopurinol


Dosage in TPMT-deficient Patients
CLINICAL PHARMACOLOGYWARNINGSPRECAUTIONS
CLINICAL PHARMACOLOGYWARNINGSPRECAUTIONS

Dosage in Renal and Hepatic Impairment


HOW SUPPLIED







STORAGE AND HANDLING

Store at 20to 25(68to 77[see USP Controlled Room Temperature]. Store in a dry place. Dispense in tight container as defined in the USP.

REFERENCES











PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Mercaptopurine

Mercaptopurine

Mercaptopurine TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-606(NDC:0054-4581)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
mercaptopurine MERCAPTOPURINE ANHYDROUS 50 mg

Inactive Ingredients

Ingredient Name Strength
STARCH, CORN
HYPROMELLOSES
ANHYDROUS LACTOSE
lactose monohydrate
MAGNESIUM STEARATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STEARIC ACID
STARCH, POTATO

Product Characteristics

Color Size Imprint Code Shape
yellow 10 mm 54;420 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-606-16 50 in 1 CANISTER

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA040528 2011-11-03


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.